MUMBAI: Drugmaker Lupin Ltd said on Wednesday it signed a licensing agreement with Sydney-based private speciality lifescience company NeuClone Pty Ltd for cell line technology .
"This agreement and such similar agreements, coupled with our own pipeline will go a long way in helping us address the impending opportunity and develop a substantial differentiated biological pipeline," President Cyrus Karkaria, said in the statement
No comments:
Post a Comment